Genetic predictor for clinical use of drugs used in the treatment of neurological conditions

Details for Australian Patent Application No. 2005215928 (hide)

Owner UCL BioMedica Plc

Inventors Sisodiya, Sanjay; Cavalleri, Gianpiero L.; Wood, Nicholas W.; Schorge, Stephanie; Tate, Sarah K.; Goldstein, David B.

Agent Davies Collison Cave

Pub. Number AU-A-2005215928

Priority 60663413 18.03.05 US

Filing date 27 September 2005

Wipo publication date 5 October 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/4166 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 October 2005 Complete Application Filed

  Priority application(s): 60663413 18.03.05 US

5 October 2006 Application Open to Public Inspection

  Published as AU-A-2005215928

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215929-Teaching aid

2005215927-Pesticidal emulsifiable concentrate